Dose-Ranging Study in Patients With COPD
Dose-Ranging Study in Patients With COPD
The trial is designed to identify an appropriate dose of QAB149 for delivery via a multiple dose inhaler for use in the COPD Phase III program.
Inclusion Criteria:
Exclusion Criteria:
San Jose, California 95117-1780, United States
Tauton, Massachusetts 02780, United States
North Dartmouth, New Hampshire 02747, United States
New Baunfels, Texas 78130, United States